Ugljesa Djuric
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ugljesa Djuric has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- James Ellis
Program in Developmental Stem Cell, and Cancer Biology, Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada
6 shared publications - Phedias Diamandis
Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada
6 shared publications Eden Fussner
Program in Genetics and Genome Biology, Hospital for Sick Children, Toronto, Ontario MSG 1L7, Canada
3 shared publications- Kevin Faust
Princess Margaret Cancer Centre Toronto Ontario Canada
3 shared publications - Rima Slim
Department of Human Genetics, McGill University Health Centre, Montreal, Canada
3 shared publications Ihor Batruch
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
2 shared publications
Latest Publications
- Open Access
- 1 October 2019
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 18 (10) , 2029-2043
Defining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry*[S]
- 1 October 2019
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 18 (10) , 2029-2043
Open AccessDefining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry*[S]
- Top Cited PapersOpen Access
- 26 April 2019
- Published by Springer Nature in npj Digital Medicine
- Vol. 2 (1) , 1-7
Physician perspectives on integration of artificial intelligence into diagnostic pathology
Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on physician stakeholders is the subject of significant speculation. There is however a dearth of information regarding the opinions, enthusiasm, and concerns of the pathology community at large. Here, we report results from a survey of 487 pathologist-respondents practicing in 54 countries, conducted to examine perspectives on AI implementation in clinical practice. Despite limitations, including difficulty with quantifying response bias and verifying identity of respondents to this anonymous and voluntary survey, several interesting findings were uncovered. Overall, respondents carried generally positive attitudes towards AI, with nearly 75% reporting interest or excitement in AI as a diagnostic tool to facilitate improvements in workflow efficiency and quality assurance in pathology. Importantly, even within the more optimistic cohort, a significant number of respondents endorsed concerns about AI, including the potential for job displacement and replacement. Overall, around 80% of respondents predicted the introduction of AI technology in the pathology laboratory within the coming decade. Attempts to identify statistically significant demographic characteristics (e.g., age, sex, type/place of practice) predictive of attitudes towards AI using Kolmogorov–Smirnov (KS) testing revealed several associations. Important themes which were commented on by respondents included the need for increasing efforts towards physician training and resolving medical-legal implications prior to the generalized implementation of AI in pathology.
- 26 April 2019
- Published by Springer Nature in npj Digital Medicine
- Vol. 2 (1) , 1-7
Top Cited PapersOpen AccessPhysician perspectives on integration of artificial intelligence into diagnostic pathology
Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on physician stakeholders is the subject of significant speculation. There is however a dearth of information regarding the opinions, enthusiasm, and concerns of the pathology community at large. Here, we report results from a survey of 487 pathologist-respondents practicing in 54 countries, conducted to examine perspectives on AI implementation in clinical practice. Despite limitations, including difficulty with quantifying response bias and verifying identity of respondents to this anonymous and voluntary survey, several interesting findings were uncovered. Overall, respondents carried generally positive attitudes towards AI, with nearly 75% reporting interest or excitement in AI as a diagnostic tool to facilitate improvements in workflow efficiency and quality assurance in pathology. Importantly, even within the more optimistic cohort, a significant number of respondents endorsed concerns about AI, including the potential for job displacement and replacement. Overall, around 80% of respondents predicted the introduction of AI technology in the pathology laboratory within the coming decade. Attempts to identify statistically significant demographic characteristics (e.g., age, sex, type/place of practice) predictive of attitudes towards AI using Kolmogorov–Smirnov (KS) testing revealed several associations. Important themes which were commented on by respondents included the need for increasing efforts towards physician training and resolving medical-legal implications prior to the generalized implementation of AI in pathology.
- 2 January 2019
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 56 (1) , 61-73
Deep learning for image analysis: Personalizing medicine closer to the point of care
The precision-based revolution in medicine continues to demand stratification of patients into smaller and more personalized subgroups. While genomic technologies have largely led this movement, diagnostic results can take days to weeks to generate. Management at, or closer to, the point of care still heavily relies on the subjective qualitative interpretation of clinical and diagnostic imaging findings. New and emerging technological advances in artificial intelligence (AI) now appear poised to help bring objectivity and precision to these traditionally qualitative analytic tools. In particular, one specific form of AI, known as deep learning, is achieving expert-level disease classifications in many areas of diagnostic medicine dependent on visual and image-based findings. Here, we briefly review concepts of deep learning, and more specifically recent developments in convolutional neural networks (CNNs), to highlight their transformative potential in personalized medicine and, in particular, diagnostic histopathology. Understanding the opportunities and challenges of these quantitative machine-based decision support tools is critical to their widespread introduction into routine diagnostics.
- 2 January 2019
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 56 (1) , 61-73
Deep learning for image analysis: Personalizing medicine closer to the point of care
The precision-based revolution in medicine continues to demand stratification of patients into smaller and more personalized subgroups. While genomic technologies have largely led this movement, diagnostic results can take days to weeks to generate. Management at, or closer to, the point of care still heavily relies on the subjective qualitative interpretation of clinical and diagnostic imaging findings. New and emerging technological advances in artificial intelligence (AI) now appear poised to help bring objectivity and precision to these traditionally qualitative analytic tools. In particular, one specific form of AI, known as deep learning, is achieving expert-level disease classifications in many areas of diagnostic medicine dependent on visual and image-based findings. Here, we briefly review concepts of deep learning, and more specifically recent developments in convolutional neural networks (CNNs), to highlight their transformative potential in personalized medicine and, in particular, diagnostic histopathology. Understanding the opportunities and challenges of these quantitative machine-based decision support tools is critical to their widespread introduction into routine diagnostics.
- Open Access
- 16 May 2018
- Published by Springer Nature in BMC Bioinformatics
- Vol. 19 (1) , 1-15
Visualizing histopathologic deep learning classification and anomaly detection using nonlinear feature space dimensionality reduction
There is growing interest in utilizing artificial intelligence, and particularly deep learning, for computer vision in histopathology. While accumulating studies highlight expert-level performance of convolutional neural networks (CNNs) on focused classification tasks, most studies rely on probability distribution scores with empirically defined cutoff values based on post-hoc analysis. More generalizable tools that allow humans to visualize histology-based deep learning inferences and decision making are scarce. Here, we leverage t-distributed Stochastic Neighbor Embedding (t-SNE) to reduce dimensionality and depict how CNNs organize histomorphologic information. Unique to our workflow, we develop a quantitative and transparent approach to visualizing classification decisions prior to softmax compression. By discretizing the relationships between classes on the t-SNE plot, we show we can super-impose randomly sampled regions of test images and use their distribution to render statistically-driven classifications. Therefore, in addition to providing intuitive outputs for human review, this visual approach can carry out automated and objective multi-class classifications similar to more traditional and less-transparent categorical probability distribution scores. Importantly, this novel classification approach is driven by a priori statistically defined cutoffs. It therefore serves as a generalizable classification and anomaly detection tool less reliant on post-hoc tuning. Routine incorporation of this convenient approach for quantitative visualization and error reduction in histopathology aims to accelerate early adoption of CNNs into generalized real-world applications where unanticipated and previously untrained classes are often encountered.
- 16 May 2018
- Published by Springer Nature in BMC Bioinformatics
- Vol. 19 (1) , 1-15
Open AccessVisualizing histopathologic deep learning classification and anomaly detection using nonlinear feature space dimensionality reduction
There is growing interest in utilizing artificial intelligence, and particularly deep learning, for computer vision in histopathology. While accumulating studies highlight expert-level performance of convolutional neural networks (CNNs) on focused classification tasks, most studies rely on probability distribution scores with empirically defined cutoff values based on post-hoc analysis. More generalizable tools that allow humans to visualize histology-based deep learning inferences and decision making are scarce. Here, we leverage t-distributed Stochastic Neighbor Embedding (t-SNE) to reduce dimensionality and depict how CNNs organize histomorphologic information. Unique to our workflow, we develop a quantitative and transparent approach to visualizing classification decisions prior to softmax compression. By discretizing the relationships between classes on the t-SNE plot, we show we can super-impose randomly sampled regions of test images and use their distribution to render statistically-driven classifications. Therefore, in addition to providing intuitive outputs for human review, this visual approach can carry out automated and objective multi-class classifications similar to more traditional and less-transparent categorical probability distribution scores. Importantly, this novel classification approach is driven by a priori statistically defined cutoffs. It therefore serves as a generalizable classification and anomaly detection tool less reliant on post-hoc tuning. Routine incorporation of this convenient approach for quantitative visualization and error reduction in histopathology aims to accelerate early adoption of CNNs into generalized real-world applications where unanticipated and previously untrained classes are often encountered.
- Open Access
- 1 September 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (9) , 1548-1562
Spatiotemporal Proteomic Profiling of Human Cerebral Development
- 1 September 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (9) , 1548-1562
Open AccessSpatiotemporal Proteomic Profiling of Human Cerebral Development
- Open Access
- 19 June 2017
- Published by Springer Nature in npj Precision Oncology
- Vol. 1 (1) , 1-5
Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
- 19 June 2017
- Published by Springer Nature in npj Precision Oncology
- Vol. 1 (1) , 1-5
Open AccessPrecision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
- Open Access
- 28 April 2016
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 30 (9) , 1101-1115
The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells
An open and decondensed chromatin organization is a defining property of pluripotency. Several epigenetic regulators have been implicated in maintaining an open chromatin organization, but how these processes are connected to the pluripotency network is unknown. Here, we identified a new role for the transcription factor NANOG as a key regulator connecting the pluripotency network with constitutive heterochromatin organization in mouse embryonic stem cells. Deletion of Nanog leads to chromatin compaction and the remodeling of heterochromatin domains. Forced expression of NANOG in epiblast stem cells is sufficient to decompact chromatin. NANOG associates with satellite repeats within heterochromatin domains, contributing to an architecture characterized by highly dispersed chromatin fibers, low levels of H3K9me3, and high major satellite transcription, and the strong transactivation domain of NANOG is required for this organization. The heterochromatin-associated protein SALL1 is a direct cofactor for NANOG, and loss of Sall1 recapitulates the Nanog-null phenotype, but the loss of Sall1 can be circumvented through direct recruitment of the NANOG transactivation domain to major satellites. These results establish a direct connection between the pluripotency network and chromatin organization and emphasize that maintaining an open heterochromatin architecture is a highly regulated process in embryonic stem cells.
- 28 April 2016
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 30 (9) , 1101-1115
Open AccessThe pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells
An open and decondensed chromatin organization is a defining property of pluripotency. Several epigenetic regulators have been implicated in maintaining an open chromatin organization, but how these processes are connected to the pluripotency network is unknown. Here, we identified a new role for the transcription factor NANOG as a key regulator connecting the pluripotency network with constitutive heterochromatin organization in mouse embryonic stem cells. Deletion of Nanog leads to chromatin compaction and the remodeling of heterochromatin domains. Forced expression of NANOG in epiblast stem cells is sufficient to decompact chromatin. NANOG associates with satellite repeats within heterochromatin domains, contributing to an architecture characterized by highly dispersed chromatin fibers, low levels of H3K9me3, and high major satellite transcription, and the strong transactivation domain of NANOG is required for this organization. The heterochromatin-associated protein SALL1 is a direct cofactor for NANOG, and loss of Sall1 recapitulates the Nanog-null phenotype, but the loss of Sall1 can be circumvented through direct recruitment of the NANOG transactivation domain to major satellites. These results establish a direct connection between the pluripotency network and chromatin organization and emphasize that maintaining an open heterochromatin architecture is a highly regulated process in embryonic stem cells.
- Open Access
- 1 April 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 76, 37-45
MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells
- 1 April 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 76, 37-45
Open AccessMECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells
- Open Access
- 18 September 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (11) , 992-996
Open and closed domains in the mouse genome are configured as 10‐nm chromatin fibres
The mammalian genome is compacted to fit within the confines of the cell nucleus. DNA is wrapped around nucleosomes, forming the classic ‘beads‐on‐a‐string’ 10‐nm chromatin fibre. Ten‐nanometre chromatin fibres are thought to condense into 30‐nm fibres. This structural reorganization is widely assumed to correspond to transitions between active and repressed chromatin, thereby representing a chief regulatory event. Here, by combining electron spectroscopic imaging with tomography, three‐dimensional images are generated, revealing that both open and closed chromatin domains in mouse somatic cells comprise 10‐nm fibres. These findings indicate that the 30‐nm chromatin model does not reflect the true regulatory structure in vivo . There is a [Hot off the Press][1] (November 2012) associated with this Scientific Report. [1]: http://dx.doi.org/10.1038/embor.2012.143
- 18 September 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (11) , 992-996
Open AccessOpen and closed domains in the mouse genome are configured as 10‐nm chromatin fibres
The mammalian genome is compacted to fit within the confines of the cell nucleus. DNA is wrapped around nucleosomes, forming the classic ‘beads‐on‐a‐string’ 10‐nm chromatin fibre. Ten‐nanometre chromatin fibres are thought to condense into 30‐nm fibres. This structural reorganization is widely assumed to correspond to transitions between active and repressed chromatin, thereby representing a chief regulatory event. Here, by combining electron spectroscopic imaging with tomography, three‐dimensional images are generated, revealing that both open and closed chromatin domains in mouse somatic cells comprise 10‐nm fibres. These findings indicate that the 30‐nm chromatin model does not reflect the true regulatory structure in vivo . There is a [Hot off the Press][1] (November 2012) associated with this Scientific Report. [1]: http://dx.doi.org/10.1038/embor.2012.143
- Open Access
- 1 December 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (50) , 43313-43323
NLRP7, a Nucleotide Oligomerization Domain-like Receptor Protein, Is Required for Normal Cytokine Secretion and Co-localizes with Golgi and the Microtubule-organizing Center
- 1 December 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (50) , 43313-43323
Open AccessNLRP7, a Nucleotide Oligomerization Domain-like Receptor Protein, Is Required for Normal Cytokine Secretion and Co-localizes with Golgi and the Microtubule-organizing Center